Oral Excipients

Shiga toxin (Stx) is the main virulence factor of Stx-producing Escherichia coli, a pathogen responsible for developing Hemolytic Uremic Syndrome. Nowadays,...

Poorly water-soluble drugs present a significant challenge in the development of oral solid dosage forms (OSDs). In formulation development the...

Abstract Oral medication administration is widely recognized as the most practical and widely used method. Medications with a short half-life...

Struggling with complex multi-excipient formulations for Orally Disintegrating Tablets (ODTs)? Look no further than HiCel HFS! This coprocessed excipient combines...

Abstract The aim of this study was to exploit the versatility of inkjet printing to develop flexible doses of drug-loaded...

The study aimed to address the challenges related to insufficient dissolution and maintenance of supersaturation in binary solid dispersions. Lacidipine,...

Introduction High-drug-loaded tablets and capsules are desirable and are manufactured using granulation as an additional step. Replacing batch wet granulation...

See some Frequently Asked Questions and the corresponding answers for Cyclodextrins and KLEPTOSE®: What are ß-Cyclodextrins (ß-CDs)? β-Cyclodextrins (β-CDs) are...

Novel p-coumaric acid microemulsion systems were developed to circumvent its absorption and bioavailability challenges. Simplex-lattice mixture design and machine learning...

The oral bioavailability of paclitaxel is limited due to low solubility and high affinity for the P-glycoprotein (P-gp) efflux transporter....